Dolby Laboratories (NYSE:DLB) Given Average Rating of “Moderate Buy” by Analysts

Shares of Dolby Laboratories (NYSE:DLB) have been assigned an average rating of “Moderate Buy” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $92.00.

A number of research analysts recently issued reports on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 8th. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Barrington Research lowered their price objective on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 19th. Robert W. Baird started coverage on Dolby Laboratories in a research note on Friday, September 5th. They set a “neutral” rating and a $74.00 target price for the company. Finally, Baird R W raised Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th.

Insider Activity at Dolby Laboratories

In other Dolby Laboratories news, SVP John D. Couling sold 6,164 shares of Dolby Laboratories stock in a transaction that occurred on Thursday, November 20th. The stock was sold at an average price of $66.12, for a total transaction of $407,563.68. Following the transaction, the senior vice president owned 115,338 shares of the company’s stock, valued at $7,626,148.56. The trade was a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Kevin J. Yeaman sold 36,699 shares of Dolby Laboratories stock in a transaction on Monday, November 24th. The shares were sold at an average price of $66.91, for a total transaction of $2,455,530.09. Following the completion of the transaction, the chief executive officer owned 114,725 shares in the company, valued at approximately $7,676,249.75. This represents a 24.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 134,730 shares of company stock worth $9,182,352. Insiders own 38.39% of the company’s stock.

Institutional Trading of Dolby Laboratories

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DLB. MAI Capital Management increased its stake in shares of Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock valued at $28,000 after acquiring an additional 162 shares during the last quarter. First Horizon Corp purchased a new stake in Dolby Laboratories in the third quarter valued at approximately $25,000. Hantz Financial Services Inc. increased its position in Dolby Laboratories by 166.7% during the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after purchasing an additional 220 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Dolby Laboratories during the first quarter worth approximately $29,000. Finally, Allworth Financial LP boosted its holdings in shares of Dolby Laboratories by 590.4% in the 2nd quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock valued at $37,000 after purchasing an additional 431 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Price Performance

Shares of DLB stock opened at $67.47 on Monday. The stock’s 50-day moving average is $67.15 and its 200 day moving average is $71.39. Dolby Laboratories has a 1-year low of $64.02 and a 1-year high of $89.66. The company has a market cap of $6.44 billion, a P/E ratio of 25.65 and a beta of 0.89.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. The firm had revenue of $307.02 million during the quarter, compared to analysts’ expectations of $305.76 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The business’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter last year, the firm earned $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.1%. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, December 2nd. Dolby Laboratories’s dividend payout ratio is currently 54.75%.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.